Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.
Genistein Combined Polysaccharide (GCP) may play a role as a secondary chemopreventive agent in the treatment of localized prostate cancer.
Prostate Cancer
DRUG: Placebo|DRUG: GCP - Genistein Combined Polysaccharide
Decrease in PSA levels in men on GCP, 6 Months
Increased PSA Doubling Time (PSADT)in men on GCP., 6 Months
Genistein Combined Polysaccharide (GCP) may play a role as a secondary chemopreventive agent in the treatment of localized prostate cancer.